Shinichiro Muraoka

Stock Analyst at Morgan Stanley

(1.41)
# 3,654
Out of 4,966 analysts
35
Total ratings
46.7%
Success rate
-0.6%
Average return

Stocks Rated by Shinichiro Muraoka

Takeda Pharmaceutical Company Limited
Sep 4, 2026
Reiterated: Buy
Price Target: ¥6,300¥7,000
Current: ¥5,666
Upside: +23.54%
Sawai Group Holdings Co., Ltd.
Aug 12, 2026
Downgraded: Hold
Price Target: ¥2,000¥1,800
Current: ¥1,581
Upside: +13.89%
Otsuka Holdings Co., Ltd.
Apr 30, 2026
Reiterated: Buy
Price Target: ¥13,200¥14,100
Current: ¥11,335
Upside: +24.39%
Kyowa Kirin Co., Ltd.
Mar 6, 2026
Downgraded: Sell
Price Target: ¥1,700
Current: ¥2,192
Upside: -22.43%
Daiichi Sankyo Company, Limited
Nov 21, 2025
Reiterated: Buy
Price Target: ¥4,750¥4,950
Current: ¥2,772
Upside: +78.57%
Sumitomo Pharma Co., Ltd.
Aug 22, 2025
Upgraded: Hold
Price Target: ¥1,350
Current: ¥1,527
Upside: n/a
SanBio Company Limited
Jul 2, 2025
Reiterated: Hold
Price Target: ¥1,400¥2,100
Current: ¥922
Upside: n/a
Astellas Pharma Inc.
May 30, 2025
Reiterated: Hold
Price Target: ¥1,750¥1,500
Current: ¥2,241
Upside: n/a
Shionogi & Co., Ltd.
May 30, 2025
Reiterated: Hold
Price Target: ¥2,750
Current: ¥2,827
Upside: n/a
Eisai Co., Ltd.
May 29, 2025
Reiterated: Hold
Price Target: ¥4,100
Current: ¥4,658
Upside: n/a
Reiterated: Hold
Price Target: ¥3,900¥3,800
Current: ¥3,386
Upside: n/a
Reiterated: Buy
Price Target: ¥7,650¥8,050
Current: ¥6,422
Upside: n/a
Downgraded: Hold
Price Target: n/a
Current: $18.26
Upside: n/a